Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,645 total articles
Incannex Healthcare has started dosing patients in its Phase 2 dose-optimization trial (DReAMzz) of IHL-42X for obstructive sleep apnea, following positive prior Phase 2 data and FDA Fast Track designation. The company also received a US patent covering IHL-42X composition expiring in 2040 and holds approximately $70 million in cash with no debt. A…
WW International, Inc., known for its science-backed weight management programs, announced the appointment of Stephen Bye as its new President and CEO. Bye brings over 30 years of leadership experience in consumer subscription and technology businesses, having previously led Ookla and held senior roles at DISH Network, Sprint, and others. His exper…
Quantum-Si is expanding its Proteus roadshow with additional stops in both the United States and Europe to advance market education and customer engagement ahead of the commercial launch of its single-molecule protein sequencing platform. The roadshow includes seminars in collaboration with academic, clinical, and biopharma partners, targeting rese…
HP Inc. announced a collaboration with Red Hat and NVIDIA to develop an open, enterprise-grade AI platform combining HP's ZGX Fury hardware with Red Hat AI Factory and NVIDIA's AI technology. This platform is designed to run AI inference closer to users, machines, and data, enabling improved AI performance, reduced setup times, and enhanced operati…
Serina Therapeutics announced the Safety Monitoring Committee's recommendation to proceed to Cohort 2 in its Phase 1b registrational study of SER-252 for advanced Parkinson's disease after favorable blinded safety, tolerability, and pharmacokinetic data from Cohort 1. Early exploratory clinical observations indicated sustained motor function improv…
SL Green Realty Corp., Manhattan's largest office landlord, announced the sale of its 110 Greene Street office building in SoHo to Natora Group for $226 million. The transaction is expected to close in Q4 2026, generating approximately $216 million in net cash proceeds to repay unsecured corporate debt. The building was brought to full occupancy wi…
Hudbay Minerals Inc. has been named a 2026 TSX30 top performer by the Toronto Stock Exchange, recognizing the company’s 427% share price growth over the past three years. The company is celebrating its centennial and highlights its strategy as a premier Americas-focused copper producer with long-life, low-cost assets in tier-one jurisdictions acros…
Rail Vision Ltd. announced the rebranding of its MainLine and ShuntingYard AI-powered railway safety products to TrackScout and YardFlow Flex, respectively. These advanced AI perception systems enhance hazard detection and operational efficiency in mainline rail networks and industrial rail yards, supported by Rail Vision's operational intelligence…
Helus Pharma, a clinical-stage pharmaceutical company focusing on novel serotonergic agonists (NSAs) for mental health conditions, announced that its CEO Michael Halstead will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The company is advancing its lead compounds HLP003 in Phase 3 for major depres…
FTI Consulting, Inc. has appointed Luis Roman as Senior Managing Director to strengthen its Construction, Projects & Assets practice, particularly in Latin America. Mr. Roman brings over 30 years of construction and project management experience with expertise in construction forensics and dispute resolution. His appointment aims to support clients…
NervGen, a NASDAQ-listed biopharmaceutical company, announced its inaugural R&D Day webcast to provide a comprehensive update on its lead neuroreparative drug candidate NVG-291. The event will feature detailed presentations on the science, clinical data, and upcoming Phase 3 RESTORE trial designed to treat chronic cervical spinal cord injury. Exper…
Telesat Corporation has been named to the 2026 TSX30, recognizing it as one of the top 30 performing stocks on the Toronto Stock Exchange based on dividend-adjusted share price performance over three years. The company's shares surged 475%, driven by advancements in its Telesat Lightspeed low Earth orbit broadband network, which plans global servic…
America’s Car-Mart, Inc. reported its first quarter fiscal 2027 financial results, showing severe declines in retail unit sales and revenue, primarily due to capital constraints limiting inventory purchases and finance receivables originations. The company sold 81.9% fewer retail units compared to the prior year, with inventory down 68.7%. The gros…
XCHG Limited, a global high-power electric vehicle charging solutions provider, announced it has regained compliance with Nasdaq's minimum bid price rule after its American Depositary Shares (ADSs) traded above $1.00 for 10 consecutive business days. This compliance removes the risk of delisting and reflects improved investor confidence.
Palvella Therapeutics has appointed Dr. James R. Treat, a nationally recognized pediatric dermatologist with nearly 20 years of experience, as Chief Medical Officer. Dr. Treat has been a longstanding clinical collaborator and investigator in Palvella's QTORIN™ trials and will lead the company’s medical strategy as they advance the potential approva…
Context Therapeutics announced the first patient dosing in the Phase 1 clinical trial of CT-202, their Nectin-4 x CD3 T cell engaging bispecific antibody, designed as a monotherapy for patients with Nectin-4-positive urothelial, colorectal, and triple-negative breast cancers. The trial aims to evaluate the safety, tolerability, pharmacokinetics, an…
Orion180 Insurance Group Inc., a rapidly growing specialty insurance provider focused on homeowners and flood insurance, announced the launch of its initial public offering (IPO) of up to 20 million shares on the Nasdaq under the ticker OIG. The offering is expected to price between $15.00 and $17.00 per share. Orion180 utilizes a proprietary techn…
TransUnion released findings from a Forrester-commissioned study showing increased frequency and impact of cyberattacks, with 60% of organizations experiencing at least one material incident in the past 18 months. The study highlights gaps in incident response readiness, the need for expert partners, and strategies to improve organizational resilie…
Gilat Satellite Networks announced that its subsidiary, Gilat DataPath, received an over $32 million order from the U.S. Department of War for multi-band Deployable Ku/Ka/X-band Earth Terminals (DKET) systems. These relocatable ground platforms support rapid deployment and resilience in mission-critical defense communications, reinforcing Gilat Def…
Bilibili Inc. has completed a $500 million offering of convertible senior notes due 2031, alongside a concurrent equity placement and share repurchases. The offering involved qualified institutional buyers outside the US, and Tencent subscribed to an additional $200 million in notes subject to shareholder approval. The company also repurchased shar…
CoinShares PLC announced that CEO Jean-Marie Mognetti will attend the Oppenheimer Fintech Leaders Conference in New York on September 15, 2026. He will conduct one-on-one meetings with investors, discussing the company's business, recent progress, and industry outlook. The company specializes in digital asset management and is publicly listed on Na…
Opus Genetics announced positive interim data from the low-dose cohort of its ongoing Phase 1/2 trial for OPGx-BEST1, a gene therapy targeting BEST1-related inherited retinal diseases. All participants showed meaningful improvements in visual function, with favorable safety and structural retinal improvements also reported. The company achieved ali…
Tilray Brands' subsidiary, Breckenridge Distillery, introduces a limited-edition whiskey collection honoring 40 years of 'The Drive' and its partnership with the Denver Broncos. The collection includes award-winning bourbon blends and a nostalgic whiskey seltzer, available in Colorado to enhance Broncos game-day experiences. This launch underscores…
Actuate Therapeutics reported promising preclinical data demonstrating that elraglusib, a GSK-3β inhibitor, when combined with RAS inhibitors zoldonrasib and daraxonrasib, exhibits synergistic antitumor activity in multiple murine and human pancreatic cancer models, including those resistant to FOLFIRINOX chemotherapy. These results, supported by i…
MapLight Therapeutics, a clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders, announced its management team's participation in the Morgan Stanley 24th Annual Global Healthcare Conference. The company aims to highlight its innovative discovery platform targeting neural circuits linked to diseases,…
